We serve (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride CAS:709031-39-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride](https://a.dearchem.com/uploads/userup/0/15ME4018-G20.png)
Chemical Name:(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride
CAS.NO:709031-39-0
Synonyms:
2-Azabicyclo[3.1.0]hexane-3-carboxamide, (1S,3S,5S)-, hydrochloride (1:1)
Molecular Formula:C6H11ClN2O
Molecular Weight: 162.61700
Physical and Chemical Properties:
Density:/
Boiling point: /
Melting point: /
Flash point:/
Refractive index: /
Specification:
Appearance: Off-white to light brown solid
Purity:≥99%
Water:≤1.0%
Loss on drying:≤0.5%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Saxagliptin CAS:361442-04-8
Intermediates of Saxagliptin hydrochloride CAS:709031-78-7
Contact us for information like (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Azabicyclo[3.1.0]hexane-3-carboxamide, (1S,3S,5S)-, hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride Use and application,(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride technical grade,usp/ep/jp grade.
Related News: Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.1,9-DIIODONONANE manufacturer Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.1-Bromo-3-iodobenzene supplier However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.3-Chloro-1-(4-octylphenyl)propan-1-one vendor At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.
